Factors Associated with Acceptance of Vaccination Against Human Papillomavirus in eThekwini District of South Africa
Authors:
- Phelele BhenguPBPhelele Bhengu
- Charles S. WiysongeCWCharles S. Wiysonge
- Patrick D. M. C. KatotoPatrick D. M. C. Katoto
- Duduzile NdwandweDNDuduzile Ndwandwe
- Sara CooperSCSara Cooper
- Sebenzile BhenguSBSebenzile Bhengu
- Akhona V. MazingisaAMAkhona V. Mazingisa
- Theresa SaberTSTheresa Saber
- Mandisi SitholeMSMandisi Sithole
- Darian SmithDSDarian Smith
- Lindiwe G. TembeLTLindiwe G. Tembe
- Paul KuodiPKPaul Kuodi
Open Access
Abstract
Background: South Africa launched a school-based human papillomavirus (HPV) vaccination programme in 2014 and has achieved a national coverage of more than 80%. However, there is subnational variation in coverage, with eThekwini District in the province of KwaZulu-Natal having the lowest coverage at 40%. Knowledge of the factors associated with vaccine acceptance in this district would inform tailored strategies to improve coverage, which could be extrapolated to similar settings. We conducted this cross-sectional study to assess the factors associated with HPV vaccine acceptance in eThekwini District. Methods: We used stratified random sampling to select caregivers of children aged 9–14 years in the district. We interviewed participants in April–May 2023 and employed bivariate and multivariate logistic regression models to assess the factors associated with HPV vaccine acceptance. Results: Of 793 individuals contacted, 713 (89.9%) participated. Most were women (86.1%) and had a mean age of 42.6 ± 11.6 years and secondary or lower education (83.8%). Most participants knew about the HPV vaccination programme (86.0%) and accepted HPV vaccination (93.5%). The latter includes 42.9% who had already vaccinated their daughters and 50.6% who were willing to allow their daughters to be vaccinated. A negligible proportion was either undecided (2.1%) or unwilling (4.4%) to accept HPV vaccination. Awareness of the programme (adjusted odds ratio [aOR] 5.22; 95% confidence interval [95%CI] 2.01–13.56), confidence in vaccine safety (aOR 19.69; 95%CI 5.86–66.15), and endorsement by religious leaders (aOR 5.06; 95%CI 1.56–16.45) were independent predictors of vaccine acceptance. Conclusions: Our findings highlight the critical role of the provision of information and education about the benefits and safety of HPV vaccination.Keywords
All Related Versions
Funding Information
- South African Medical Research Council (43500)
- South African National Department of Health (43500)
This publication has 24 references indexed in Scilit:
- Defining drivers of human papillomavirus (HPV) vaccine uptake in migrant populations globally and strategies and interventions to improve coverage: a systematic reviewmedRxiv, 2025
- From hesitancy to decision: shifts from intentions to uptake of Influenza and COVID-19 vaccinesEuropean Journal of Public Health, 2024
- Factors that influence the uptake and delivery of HPV vaccines in migrants: a systematic reviewEuropean Journal of Public Health, 2023
- Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic reviewBMC Public Health, 2023
- From COVID-19 Vaccination Intention to Actual Vaccine Uptake: A Longitudinal Study Among Chinese Adults After Six Months of a National Vaccination CampaignExpert Review of Vaccines, 2022
- Gap between willingness and behavior in the vaccination against influenza, pneumonia, and herpes zoster among Chinese aged 50–69 yearsExpert Review of Vaccines, 2021
- HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019Preventive Medicine, 2021
- A systematic literature review to examine the potential for social media to impact HPV vaccine uptake and awareness, knowledge, and attitudes about HPV and HPV vaccinationHuman Vaccines & Immunotherapeutics, 2019
- Addressing barriers to vaccine acceptance: an overviewHuman Vaccines & Immunotherapeutics, 2017
- The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United StatesSexually Transmitted Diseases, 2014